GUO Ai-lin, ZONG Sa. HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 210-212. DOI: 10.3969/j.issn.1671-5144.2008.04.005
|
Citation:
|
GUO Ai-lin, ZONG Sa. HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 210-212. DOI: 10.3969/j.issn.1671-5144.2008.04.005
|
GUO Ai-lin, ZONG Sa. HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 210-212. DOI: 10.3969/j.issn.1671-5144.2008.04.005
|
Citation:
|
GUO Ai-lin, ZONG Sa. HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 210-212. DOI: 10.3969/j.issn.1671-5144.2008.04.005
|
DownLoad: